1762 related articles for article (PubMed ID: 8226281)
1. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits tumor cell-induced platelet aggregation.
Sheu JR; Lin CH; Peng HC; Teng CM; Huang TF
Jpn J Cancer Res; 1993 Oct; 84(10):1062-71. PubMed ID: 8226281
[TBL] [Abstract][Full Text] [Related]
2. Triflavin, an Arg-Gly-Asp containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line.
Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
Thromb Res; 1992 Jun; 66(6):679-91. PubMed ID: 1519227
[TBL] [Abstract][Full Text] [Related]
3. The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by saos-2 human osteosarcoma cells.
Chiang HS; Yang RS; Huang TF
Br J Cancer; 1995 Feb; 71(2):265-70. PubMed ID: 7841039
[TBL] [Abstract][Full Text] [Related]
4. Characterization of platelet aggregation induced by human breast carcinoma and its inhibition by snake venom peptides, trigramin and rhodostomin.
Chiang HS; Swaim MW; Huang TF
Breast Cancer Res Treat; 1995 Mar; 33(3):225-35. PubMed ID: 7749150
[TBL] [Abstract][Full Text] [Related]
5. Characterization of platelet aggregation induced by human colon adenocarcinoma cells and its inhibition by snake venom peptides, trigramin and rhodostomin.
Chiang HS; Swaim MW; Huang TF
Br J Haematol; 1994 Jun; 87(2):325-31. PubMed ID: 7947275
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of platelet aggregation induced by PC-3 human prostate adenocarcinoma cells and inhibited by venom peptides, trigramin and rhodostomin.
Swaim MW; Chiang HS; Huang TF
Eur J Cancer; 1996 Apr; 32A(4):715-21. PubMed ID: 8695278
[TBL] [Abstract][Full Text] [Related]
7. Triflavin, an Arg-Gly-Asp-containing antiplatelet peptide inhibits cell-substratum adhesion and melanoma cell-induced lung colonization.
Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
Jpn J Cancer Res; 1992 Aug; 83(8):885-93. PubMed ID: 1399825
[TBL] [Abstract][Full Text] [Related]
8. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
[TBL] [Abstract][Full Text] [Related]
9. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits human cervical carcinoma (HeLa) cell-substratum adhesion through an RGD-dependent mechanism.
Sheu JR; Lin CH; Peng HC; Huang TF
Peptides; 1994; 15(8):1391-8. PubMed ID: 7700842
[TBL] [Abstract][Full Text] [Related]
10. Interaction of thrombin-activated platelets with extracellular matrices (fibronectin and vitronectin): comparison of the activity of Arg-Gly-Asp-containing venom peptides and monoclonal antibodies against glycoprotein IIb/IIIa complex.
Sheu JB; Ko WC; Hung WC; Peng HC; Huang TF
J Pharm Pharmacol; 1997 Jan; 49(1):78-84. PubMed ID: 9120775
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tumor cell-induced platelet aggregation and experimental tumor metastasis by the synthetic Gly-Arg-Gly-Asp-Ser peptide.
Ugen KE; Mahalingam M; Klein PA; Kao KJ
J Natl Cancer Inst; 1988 Nov; 80(18):1461-6. PubMed ID: 3184195
[TBL] [Abstract][Full Text] [Related]
12. Triflavin, an Arg-Gly-Asp-Containing Peptide, Inhibits B16-F10 Mouse Melanoma Cell Adhesion to Matrix Proteins via Direct Binding to Tumor Cells.
Sheu JR; Huang TF
J Biomed Sci; 1996; 3(5):359-364. PubMed ID: 11725118
[TBL] [Abstract][Full Text] [Related]
13. Triflavin inhibits platelet-induced vasoconstriction in de-endothelialized aorta.
Sheu JR; Yen MH; Hung WC; Lee YM; Su CH; Huang TF
Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3461-8. PubMed ID: 9437193
[TBL] [Abstract][Full Text] [Related]
14. Protracted treatment with phorbol ester modulates J-7 human hepatoma-cell-induced aggregation and coagulation of human platelet-rich plasma.
Ko FN; Yu SM; Teng CM
Int J Cancer; 1994 Dec; 59(5):706-11. PubMed ID: 7960244
[TBL] [Abstract][Full Text] [Related]
15. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.
Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR
Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729
[TBL] [Abstract][Full Text] [Related]
16. A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom.
Huang TF; Sheu JR; Teng CM
Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):351-7. PubMed ID: 1859363
[TBL] [Abstract][Full Text] [Related]
17. Involvement of platelet membrane glycoprotein Ib and glycoprotein IIb/IIIa complex in thrombin-dependent and -independent platelet aggregations induced by tumor cells.
Kitagawa H; Yamamoto N; Yamamoto K; Tanoue K; Kosaki G; Yamazaki H
Cancer Res; 1989 Feb; 49(3):537-41. PubMed ID: 2910473
[TBL] [Abstract][Full Text] [Related]
18. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits the adhesion of tumor cells to matrix proteins via binding to multiple integrin receptors expressed on human hepatoma cells.
Sheu JR; Lin CH; Peng HC; Huang TF
Proc Soc Exp Biol Med; 1996 Oct; 213(1):71-9. PubMed ID: 8820826
[TBL] [Abstract][Full Text] [Related]
19. Ex-vivo and in-vivo antithrombotic effect of triflavin, an RGD-containing peptide.
Sheu JR; Huang TF
J Pharm Pharmacol; 1994 Jan; 46(1):58-62. PubMed ID: 8201528
[TBL] [Abstract][Full Text] [Related]
20. Triflavin, an Arg-Gly-Asp-containing peptide, prevents platelet plug formation in in vivo experiments.
Sheu JR; Yen MH; Peng HC; Chang MC; Huang TF
Eur J Pharmacol; 1995 Dec; 294(1):231-8. PubMed ID: 8788436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
